Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group

Arthritis and Rheumatism
H PaulusH J Williams

Abstract

A composite index for estimating improvement in individual rheumatoid arthritis (RA) patients during trials of slow-acting, disease-modifying antirheumatic drugs (DMARDs) was developed by analyzing the responses of 130 placebo-treated participants in Cooperative Systematic Studies of Rheumatic Diseases studies. If responses in 4 of 6 selected measures were required for improvement (by greater than or equal to 20% for morning stiffness, Westergren erythrocyte sedimentation rate, joint pain/tenderness score, and joint swelling score, and by greater than or equal to 2 grades on a 5-grade scale, or from grade 2 to grade 1 for patient's and physician's overall assessments of current disease severity), few placebo-treated patients qualified as improved, whereas significantly more DMARD-treated patients demonstrated improvement. The proposed index appears to be useful in estimating the probability that an RA patient will improve if taking a placebo during a DMARD trial, and may be a useful tool for analysis of DMARD studies.

Associated Clinical Trials

References

Mar 1, 1977·Arthritis and Rheumatism·I L DwoshM A Ogryzlo
Sep 28, 1974·British Medical Journal·H L CurreyB Owen-Smith
Nov 1, 1971·Annals of the Rheumatic Diseases·R J McGuire, V Wright

❮ Previous
Next ❯

Citations

Mar 4, 1998·Arthritis and Rheumatism·J R Kalden, J Sieper
Dec 31, 1998·Arthritis and Rheumatism·B BresnihanP Musikic
Oct 11, 2001·Arthritis and Rheumatism·E H ChoyG S Panayi
Feb 13, 2002·Arthritis and Rheumatism·UNKNOWN American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines
Jul 13, 2002·Arthritis and Rheumatism·Tino MunsterDaniel E Furst
Jun 1, 1996·Arthritis and Rheumatism·E M GravalleseM E Weinblatt
Mar 1, 1997·Arthritis and Rheumatism·L W MorelandW J Koopman
Oct 29, 1998·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·A Escalante
Jul 15, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Kathleen CareyAbass Alavi
Feb 24, 2006·Zeitschrift für Rheumatologie·D AletahaJ Smolen
Feb 1, 1997·International Journal of Immunopharmacology·M Wu
Nov 1, 1995·Baillière's Clinical Rheumatology·M J Elliott, R N Maini
Feb 23, 2002·Joint, Bone, Spine : Revue Du Rhumatisme·Marc Feldmann, Ravinder N Maini
Aug 14, 2003·Best Practice & Research. Clinical Rheumatology·Theodore Pincus, Tuulikki Sokka
May 30, 2002·Nature Reviews. Immunology·Marc Feldmann
Apr 3, 2009·Current Opinion in Rheumatology·Helene Alexanderson
Jun 1, 1995·Journal of Clinical Pharmacy and Therapeutics·S L Dahl
Apr 1, 1997·Australian and New Zealand Journal of Medicine·F M McQueen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.